The use of Esketamine in CT-guided percutaneous liver tumor ablation reduces the consumption of remifentanil: a randomized, controlled, double-blind trial
@article{ATM97171, author = {Yanbing Su and Jianxing Zhang and Huanwei Wang and Yangkui Gu and Handong Ouyang and Wan Huang}, title = {The use of Esketamine in CT-guided percutaneous liver tumor ablation reduces the consumption of remifentanil: a randomized, controlled, double-blind trial}, journal = {Annals of Translational Medicine}, volume = {10}, number = {12}, year = {2022}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/97171} }